Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
International Journal of Neurology and Neurosurgery

Volume  9, Issue 2, Jul-Dec 2017, Pages 172-186
 

Case Report

Parkinson’s Disease and Therapeutic Strategies

Rajesh Singh Pukhrambam*, Abuno Thepa**, Nukshimenla Jamir**, Limamanen Phom**, Sarat Chandra Yenisetti***

*Assistant Professor and Research Scholar, **Research Scholar, ***Associate Professor, Drosophila Neurobiology Laboratory Department of Zoology, Nagaland University (Central) Lumami, Nagaland 798627, India.

Choose an option to locate / access this Article:
90 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: http://dx.doi.org/10.21088/ijnns.0975.0223.9217.16

Abstract

Parkinson’s disease is the second most common aged associated neurodegenerative disorder after Alzhiemer affecting approximately 1% of the population above the age 50. James Parkinson for the first time medically described Parkinson disease as a neurological disorder in his famous work “An Essay of the shaking palsy”. The pathological hallmark of PD is selective and progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta of human brain and the accumulation of Lewy bodies in the surviving neurons. Cardinal symptoms of Parkinson’s disease include resting tremor, rigidity, postural instability. Besides motor symptoms, several nonmotor symptoms are manifested many years before the onset of motor symptoms. Parkinson’s disease is classified into sporadic and familial PD. Therapeutic strategies prior to Levodopa and Deep Brain stimulation include bloodletting from the neck, vesicatories, shaking chair, hydrotherapy, spa treatments, light exercise and treating with hyoscyamine, arsenic, morphia, conium, Indian hemp” (cannabis). Though levodopa is the leading treatment for PD, it has many limitations. Stem cell therapy appears to be a promising therapy to replenish degenerated dopaminergic neurons.

Keywords: Parkinson’s Disease; Motor Symptoms; NonMotor Symptoms; Deep Brain Stimulation; Levodopa; Stem Cell Therapy; Biomarkers. 


Corresponding Author : Sarat Chandra Yenisetti, Associate Professor, Drosophila Neurobiology Laboratory Department of Zoology, Nagaland University (Central) Lumami, Nagaland 798627, India.